# Pfizer Inc. (PFE) — Q1-2021 Earnings Results

**Report date:** 2021-05-04 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q1-2021

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Up 0.3%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.93 | N/A | +17.42% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed optimism about the company's current trajectory, particularly in vaccine sales. They emphasized their commitment to innovation and efficiency.

**Key quotes:**

> Management highlighted strong performance in their vaccine segment.

> They noted ongoing research and development efforts for future products.

> The company remains focused on maintaining operational efficiency.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Pfizer's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. The stock reacted modestly, rising 0.3%, likely driven by investor confidence in the company's vaccine performance and future product pipeline. However, the lack of revenue data and guidance may leave some investors cautious about the company's overall outlook.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q1-2021_